Professor of One Health. A Franco-British healthcare scientist with an extensive academic and translational research background, recognised internationally for contributions to One Health, analytical chemistry, biosensors, quantum sensing, and diagnostic innovation.

His research portfolio covers One Health frameworks, benchtop nuclear magnetic resonance (NMR) technologies, biosensing systems, supramolecular chemistry, and nitrogen-vacancy quantum sensing. These areas underpin applications in human, animal, and environmental health, bridging academic discovery with real-world clinical and industrial needs.

Professor Wilson has held senior scientific and academic appointments across several institutions, including the University of Bath, De Montfort University, Nottingham Trent University, and within the UK National Health Service. His career spans molecular and analytical sciences, biotechnology, translational medicine, and applied environmental and animal health.

He serves on numerous scientific and governmental advisory groups, including committees focused on genetics, toxicology, and comparative medicine. He chairs the Royal Society of Biology East Midlands Branch and holds leadership positions across several scientific organisations.

His honours include Forbes 30 Under 30 (Science & Healthcare), the Royal Society of Chemistry's Joseph Black Medal for research-led teaching, and inclusion as "Krypton" in IUPAC's Periodic Table of Younger Chemists. He is a Fellow of the Royal Society of Biology, a Section President of the Royal Society of Medicine, and a Fellow of the Linnean Society of London.

Pioneer in low-field NMR spectroscopy and metabolomics. Phase 3 clinical trial co-investigator on the TACKLE study (AstraZeneca tixagevimab–cilgavimab), published in The Lancet Respiratory Medicine.